NEW HORIZONS DIAGNOSTICS

In 2020, NHD began developing two new projects with DTRA to develop a unique approach to COVID-19. Our goal is to create a rapid, reliable, and sensitive lateral flow immunoassay test by using research from enzyme-linked immunoassay (ELISA) and Peptide Microarray... New Horizons Diagnostics has over 30 years of experience in developing and manufacturing rapid detection tests for bacteria and toxins in human, environmental, surface, food, and water samples. We also have experience in the development of therapeutic and preventative agents for treating conditions caused by bacterial or viral infection... Innovation and critical alliances have hallmarked the continuing success of New Horizons. The company has expanded its technology base to include the prevention and treatment of autoimmune and infectious diseases. These include the use of humanized anti-cytokine monoclonal antibodies and the treatment of bacterial infection with Phage associated lytic enzymes. New test formats include a..

Also known as: New Horizons Diagnostic Corporation, New Horizons Diagnostics Corp., New Horizons Diagnostics Corporation

Primary location: Baltimore United States